Regeneron Pharmaceuticals (REGN) Receivables (2009 - 2026)
Regeneron Pharmaceuticals (REGN) posted Receivables of $6.57 billion for Q2 2026, up 17.0% from $5.61 billion a year earlier and up 14.6% from the prior quarter.
Powered by 
Analysis
Regeneron Pharmaceuticals (REGN) Receivables (2009 - 2026) Analysis & Trends
At the end of FY2025, Regeneron Pharmaceuticals' Receivables came in at $5.74 billion, down 7.6% from FY2024.
- Annual Receivables shows a five-year compound annual growth rate of 6.9% (FY2020 to FY2025).
- In prior years, Regeneron Pharmaceuticals' Receivables was $6.21 billion in FY2024 (+9.6%), $5.67 billion in FY2023 (+6.4%), $5.33 billion in FY2022 (-11.7%) and $6.04 billion in FY2021 (+46.7%).
- The Q2 2026 figure stands as the highest quarterly Receivables since Q2 2021.
- On a year-over-year basis, Receivables increased in five of the last eight quarters, with growth averaging 3.7%.
- The strongest year-over-year quarter for Receivables in the past five years was Q3 2021, with growth of 53.4%; the weakest was Q2 2022, with a decline of 26.3%.
- According to Business Quant data, Receivables for the three prior quarters was $5.73 billion (Q1 2026), $5.74 billion (Q4 2025) and $5.69 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,221.09 Bn | 1,194.71 Bn | 20.46 Bn | 25.23 Bn |
| 2 | Johnson & Johnson | 656.38 Bn | 576.24 Bn | 17.30 Bn | 18.99 Bn |
| 3 | AbbVie | 510.79 Bn | 478.80 Bn | 13.12 Bn | 13.51 Bn |
| 4 | Merck | 363.00 Bn | 317.38 Bn | 12.21 Bn | 12.56 Bn |
| 5 | Novartis Ag | 313.89 Bn | 287.12 Bn | - | - |
| 6 | Astrazeneca | 290.02 Bn | 263.91 Bn | 13.26 Bn | 16.16 Bn |
| 7 | Amgen | 249.59 Bn | 204.98 Bn | 7.24 Bn | 10.23 Bn |
| 8 | Gilead Sciences | 208.15 Bn | 183.26 Bn | 6.73 Bn | 5.01 Bn |
| 9 | Pfizer | 170.74 Bn | 118.10 Bn | 12.56 Bn | 14.19 Bn |
| 10 | Regeneron Pharmaceuticals | 91.70 Bn | 57.05 Bn | 4.54 Bn | 7.58 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 7.58 Bn |
| Jun 30, 2026 | 6.57 Bn |
| Mar 31, 2026 | 5.73 Bn |
| Dec 31, 2025 | 5.74 Bn |
| Sep 30, 2025 | 5.69 Bn |
| Jun 30, 2025 | 5.61 Bn |
| Mar 31, 2025 | 5.56 Bn |
| Dec 31, 2024 | 6.21 Bn |
| Sep 30, 2024 | 6.11 Bn |
| Jun 30, 2024 | 5.72 Bn |
| Mar 31, 2024 | 5.22 Bn |
| Dec 31, 2023 | 5.67 Bn |
| Sep 30, 2023 | 5.58 Bn |
| Jun 30, 2023 | 5.12 Bn |
| Mar 31, 2023 | 5.12 Bn |
| Dec 31, 2022 | 5.33 Bn |
| Sep 30, 2022 | 5.55 Bn |
| Jun 30, 2022 | 5.16 Bn |
| Mar 31, 2022 | 4.84 Bn |
| Dec 31, 2021 | 6.04 Bn |
API Access
Regeneron Pharmaceuticals Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables&ticker=REGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables", "ticker": "REGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables&ticker=REGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();